Tmem161a regulates bone formation and bone strength through the P38 MAPK pathway

Area of Science:

• Bone Biology
• Genetics
• Cellular Signaling

Background:

• Bone remodeling is a complex process influenced by genetic, metabolic, and environmental factors.
• The specific genetic regulators of bone structure and function are not fully understood.
• Transmembrane 161a (Tmem161a) is a gene whose role in bone biology has not been previously investigated.

Purpose of the Study:

• To investigate the function of Tmem161a in bone structure and strength.
• To determine the molecular mechanisms by which Tmem161a influences bone cells.
• To assess the impact of Tmem161a depletion on bone remodeling in vivo and in vitro.

Main Methods:

• Comparative analysis of wild-type (WT) and Tmem161a-depleted (Tmem161aGT/GT) mouse femurs using histological, morphological, and bone strength assessments.
• In vitro studies involving MC3T3-e1 cells with Tmem161a overexpression, knockdown, and knockout to examine osteoblast differentiation and mineral deposition.
• Molecular analyses including microarray and western blot to identify signaling pathways affected by Tmem161a, alongside alkaline phosphatase (ALP) and flow cytometry assays.

Main Results:

• Tmem161a was expressed in osteoblasts of WT mouse femurs but depleted in Tmem161aGT/GT mice.
• Tmem161aGT/GT mice exhibited significantly increased cortical bone mineral density, thickness, and overall bone strength.
• Tmem161a depletion in MC3T3-e1 cells reversed the decreased expression of alkaline phosphatase (ALP) and Osterix observed with Tmem161a overexpression.
• Knockout of Tmem161a led to upregulation of the P38 MAPK pathway and conferred resistance to oxidative stress in MC3T3-e1 cells.

Conclusions:

• Tmem161a acts as a regulator of P38 MAPK signaling in bone cells.
• Depletion of Tmem161a results in enhanced bone mass and strength in mice.
• Tmem161a plays a significant role in maintaining bone homeostasis and response to stress.